Cargando…
MYCN driven oncogenesis involves cooperation with WDR5 to activate canonical MYC targets and G9a to repress differentiation genes
MYCN activates canonical MYC targets involved in ribosome biogenesis, protein synthesis and represses neuronal differentiation genes to drive oncogenesis in neuroblastoma (NB). How MYCN orchestrates global gene expression remains incompletely understood. Our study finds that MYCN binds promoters to...
Autores principales: | Liu, Zhihui, Zhang, Xiyuan, Xu, Man, Hong, Jason J., Ciardiello, Amanda, Lei, Haiyan, Shern, Jack F., Thiele, Carol J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541123/ https://www.ncbi.nlm.nih.gov/pubmed/37781575 http://dx.doi.org/10.1101/2023.07.11.548643 |
Ejemplares similares
-
Loss of CASZ1 tumor suppressor linked to oncogenic subversion of neuroblastoma core regulatory circuitry
por: Liu, Zhihui, et al.
Publicado: (2022) -
MYCN and the epigenome
por: He, Stanley, et al.
Publicado: (2013) -
Targeting MYCN in Pediatric and Adult Cancers
por: Liu, Zhihui, et al.
Publicado: (2021) -
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
por: Lodrini, Marco, et al.
Publicado: (2013) -
Targeting MYC through WDR5
por: Thomas, Lance R., et al.
Publicado: (2020)